Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (51-60 of 355) with videos related to

Pageof 36
Sort By:
Pain|April 1, 1991
Comprehensive multidisciplinary treatment of chronic pain: a follow-up study of treated and non-treated groupsWilliam W Deardorff, Howard S Rubin, David W Scott
Journal of the American Heart Association|August 1, 2013
Heterogenic endothelial responses to inflammation: role for differential N-glycosylation and vascular bed of originDavid W Scott, Matthew O Vallejo, Rakesh P Patel
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathwayYan Su, Gregory Carey, Maja Maric, et al.
Blood|March 19, 2013
Progress toward inducing immunologic tolerance to factor VIIIDavid W Scott, Kathleen P Pratt, Carol H Miao
International Immunology|July 4, 2002
In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragmentMoustapha el-Amine, Jennifer A Hinshaw, David W Scott
Seminars in Hematology|December 27, 2023
Biological heterogeneity in diffuse large B-cell lymphomaLaura K Hilton, David W Scott, Ryan D Morin
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2010
B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cellsJonathan Skupsky, Ai-Hong Zhang, Yan Su, et al.
Human Gene Therapy|July 24, 2010
Gene therapy with IgG-HY fusion proteins to reduce male-specific T-cell reactivity in vitroMiranda P Dierselhuis, Ellen Schrama, David W Scott, et al.
Trends in Molecular Medicine|August 12, 2009
Gene therapy and bone marrow stem-cell transfer to treat autoimmune diseaseFrank Alderuccio, James Chan, David W Scott, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 27, 2017
Hemophilia A inhibitor treatment: the promise of engineered T-cell therapyKalpana Parvathaneni, Maha Abdeladhim, Kathleen P Pratt, et al.
Pageof 36

Showing results (51-60 of 355) with videos related to

Sort By:
Pageof 36
Pain|April 1, 1991
Comprehensive multidisciplinary treatment of chronic pain: a follow-up study of treated and non-treated groupsWilliam W Deardorff, Howard S Rubin, David W Scott
Journal of the American Heart Association|August 1, 2013
Heterogenic endothelial responses to inflammation: role for differential N-glycosylation and vascular bed of originDavid W Scott, Matthew O Vallejo, Rakesh P Patel
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2008
B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathwayYan Su, Gregory Carey, Maja Maric, et al.
Blood|March 19, 2013
Progress toward inducing immunologic tolerance to factor VIIIDavid W Scott, Kathleen P Pratt, Carol H Miao
International Immunology|July 4, 2002
In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragmentMoustapha el-Amine, Jennifer A Hinshaw, David W Scott
Seminars in Hematology|December 27, 2023
Biological heterogeneity in diffuse large B-cell lymphomaLaura K Hilton, David W Scott, Ryan D Morin
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2010
B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cellsJonathan Skupsky, Ai-Hong Zhang, Yan Su, et al.
Human Gene Therapy|July 24, 2010
Gene therapy with IgG-HY fusion proteins to reduce male-specific T-cell reactivity in vitroMiranda P Dierselhuis, Ellen Schrama, David W Scott, et al.
Trends in Molecular Medicine|August 12, 2009
Gene therapy and bone marrow stem-cell transfer to treat autoimmune diseaseFrank Alderuccio, James Chan, David W Scott, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 27, 2017
Hemophilia A inhibitor treatment: the promise of engineered T-cell therapyKalpana Parvathaneni, Maha Abdeladhim, Kathleen P Pratt, et al.
Pageof 36